NO910033L - Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.Info
- Publication number
- NO910033L NO910033L NO91910033A NO910033A NO910033L NO 910033 L NO910033 L NO 910033L NO 91910033 A NO91910033 A NO 91910033A NO 910033 A NO910033 A NO 910033A NO 910033 L NO910033 L NO 910033L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- compounds
- preparation
- phenoxypropylamino
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898910374A GB8910374D0 (en) | 1989-05-05 | 1989-05-05 | Chemical compounds |
| PCT/GB1990/000668 WO1990013535A1 (en) | 1989-05-05 | 1990-04-30 | Compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO910033D0 NO910033D0 (no) | 1991-01-04 |
| NO910033L true NO910033L (no) | 1991-03-04 |
Family
ID=10656286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91910033A NO910033L (no) | 1989-05-05 | 1991-01-04 | Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0426804B1 (no) |
| JP (1) | JPH03506037A (no) |
| KR (1) | KR920701123A (no) |
| CN (1) | CN1047857A (no) |
| AT (1) | ATE100439T1 (no) |
| AU (1) | AU622027B2 (no) |
| BG (1) | BG93509A (no) |
| CA (1) | CA2015705A1 (no) |
| DD (1) | DD300542A5 (no) |
| DE (1) | DE69006178T2 (no) |
| DK (1) | DK0426804T3 (no) |
| ES (1) | ES2062526T3 (no) |
| FI (1) | FI910059A0 (no) |
| GB (2) | GB8910374D0 (no) |
| GR (1) | GR1001610B (no) |
| HU (1) | HUT58277A (no) |
| IE (1) | IE63533B1 (no) |
| MW (1) | MW4190A1 (no) |
| NO (1) | NO910033L (no) |
| NZ (1) | NZ233425A (no) |
| PL (1) | PL285062A1 (no) |
| PT (1) | PT93954A (no) |
| WO (1) | WO1990013535A1 (no) |
| ZA (1) | ZA903111B (no) |
| ZW (1) | ZW6790A1 (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5502078A (en) * | 1991-05-28 | 1996-03-26 | Zeneca Limited | Chemical compounds |
| GB9111425D0 (en) * | 1991-05-28 | 1991-07-17 | Ici Plc | Chemical compounds |
| GB9111426D0 (en) * | 1991-05-28 | 1991-07-17 | Ici Plc | Chemical compounds |
| NO179246C (no) * | 1991-11-20 | 1996-09-04 | Sankyo Co | Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav |
| GB9207964D0 (en) * | 1992-04-10 | 1992-05-27 | Ici Plc | Chemical compounds |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US463323A (en) * | 1891-11-17 | Temporary binder | ||
| GB1245148A (en) * | 1968-11-18 | 1971-09-08 | Pfizer Ltd | Propanolamine derivatives |
| US4263323A (en) * | 1976-10-07 | 1981-04-21 | Aktiebolaget Hassle | β-Receptor blocking compounds and treatment of cardiovascular disorders therewith |
| DE3271132D1 (en) * | 1981-07-11 | 1986-06-19 | Beecham Group Plc | Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application |
| GB8519154D0 (en) * | 1985-07-30 | 1985-09-04 | Ici Plc | Aromatic ethers |
-
1989
- 1989-05-05 GB GB898910374A patent/GB8910374D0/en active Pending
-
1990
- 1990-04-20 GB GB909008867A patent/GB9008867D0/en active Pending
- 1990-04-23 IE IE143890A patent/IE63533B1/en not_active IP Right Cessation
- 1990-04-24 NZ NZ233425A patent/NZ233425A/en unknown
- 1990-04-24 ZA ZA903111A patent/ZA903111B/xx unknown
- 1990-04-26 MW MW41/90A patent/MW4190A1/xx unknown
- 1990-04-30 EP EP90907243A patent/EP0426804B1/en not_active Expired - Lifetime
- 1990-04-30 DE DE90907243T patent/DE69006178T2/de not_active Expired - Fee Related
- 1990-04-30 WO PCT/GB1990/000668 patent/WO1990013535A1/en active IP Right Grant
- 1990-04-30 HU HU903384A patent/HUT58277A/hu unknown
- 1990-04-30 CA CA002015705A patent/CA2015705A1/en not_active Abandoned
- 1990-04-30 ZW ZW67/90A patent/ZW6790A1/xx unknown
- 1990-04-30 JP JP2506670A patent/JPH03506037A/ja active Pending
- 1990-04-30 KR KR1019910700017A patent/KR920701123A/ko not_active Application Discontinuation
- 1990-04-30 AT AT90907243T patent/ATE100439T1/de not_active IP Right Cessation
- 1990-04-30 ES ES90907243T patent/ES2062526T3/es not_active Expired - Lifetime
- 1990-04-30 AU AU55403/90A patent/AU622027B2/en not_active Ceased
- 1990-04-30 DK DK90907243.1T patent/DK0426804T3/da active
- 1990-05-04 PT PT93954A patent/PT93954A/pt not_active Application Discontinuation
- 1990-05-04 PL PL28506290A patent/PL285062A1/xx unknown
- 1990-05-04 DD DD340389A patent/DD300542A5/de unknown
- 1990-05-04 GR GR900100332A patent/GR1001610B/el unknown
- 1990-05-05 CN CN90102708A patent/CN1047857A/zh active Pending
- 1990-12-21 BG BG093509A patent/BG93509A/bg unknown
-
1991
- 1991-01-04 FI FI910059A patent/FI910059A0/fi not_active Application Discontinuation
- 1991-01-04 NO NO91910033A patent/NO910033L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL285062A1 (en) | 1992-01-13 |
| ZW6790A1 (en) | 1991-02-27 |
| HU903384D0 (en) | 1991-05-28 |
| KR920701123A (ko) | 1992-08-11 |
| GB8910374D0 (en) | 1989-06-21 |
| ES2062526T3 (es) | 1994-12-16 |
| GB9008867D0 (en) | 1990-06-20 |
| MW4190A1 (en) | 1991-03-13 |
| NZ233425A (en) | 1992-07-28 |
| ZA903111B (en) | 1991-12-24 |
| DE69006178D1 (de) | 1994-03-03 |
| JPH03506037A (ja) | 1991-12-26 |
| EP0426804A1 (en) | 1991-05-15 |
| CN1047857A (zh) | 1990-12-19 |
| BG93509A (bg) | 1993-12-24 |
| WO1990013535A1 (en) | 1990-11-15 |
| EP0426804B1 (en) | 1994-01-19 |
| DD300542A5 (de) | 1992-06-17 |
| AU5540390A (en) | 1990-11-29 |
| GR1001610B (el) | 1994-07-29 |
| GR900100332A (en) | 1991-10-10 |
| DE69006178T2 (de) | 1994-05-05 |
| DK0426804T3 (da) | 1994-05-30 |
| CA2015705A1 (en) | 1990-11-05 |
| NO910033D0 (no) | 1991-01-04 |
| IE901438L (en) | 1990-11-05 |
| FI910059A0 (fi) | 1991-01-04 |
| IE63533B1 (en) | 1995-05-03 |
| HUT58277A (en) | 1992-02-28 |
| PT93954A (pt) | 1991-01-08 |
| ATE100439T1 (de) | 1994-02-15 |
| AU622027B2 (en) | 1992-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO161910C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetralinderivater. | |
| AU1808488A (en) | Compounds for the treatment of alzheimer's disease | |
| DK0524781T3 (da) | Terapeutiske amider | |
| NO890259L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| ES2080297T3 (es) | Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos. | |
| NO902800L (no) | Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener. | |
| NO166939C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater. | |
| DE69413118D1 (de) | Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität | |
| DE68904462D1 (de) | 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten. | |
| NO910033D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser. | |
| IL83775A0 (en) | Fumaramide derivatives and pharmaceutical compositions containing them for treating skin diseases | |
| NZ217418A (en) | Tricyclic heterocyclic compounds and pharmaceutical compositions | |
| NO162557C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner. | |
| ATE183088T1 (de) | Arzneimittel zur behandlung von hauterkrankungen | |
| ES2042530T3 (es) | Procedimiento para la preparacion de derivados de acido ursodesoxicolico terapeuticamente activos. | |
| NO821083L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater | |
| NO903585D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner. | |
| DE59107405D1 (de) | Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| SE9000608D0 (sv) | Instrumentarium foer kirurgisk behandling av cervikala hoeftfrakturer |